Mutation-based circulating tumor DNA detection approach to monitoring the therapy response in breast cancer

Mutation-based circulating tumor DNA detection approach to monitoring the therapy response in breast cancer

Bibliographic Details
Main Authors:	Jiaqi Liu, Yansong Huang, Xiang Wang
Format:	Article
Language:	English
Published:	Elsevier 2023-12-01
Series:	Journal of the National Cancer Center
Online Access:	http://www.sciencedirect.com/science/article/pii/S2667005423000613

Similar Items

Concurrent Detection of Circulating Tumor Cells and Circulating Tumor DNA in Triple-negative Breast Cancer
by: Henry L Gomez, et al.
Published: (2021-10-01)

Rescue of Non-Informative Circulating Tumor DNA to Monitor the Mutational Landscape in NSCLC
by: Stefanie Mayer, et al.
Published: (2020-07-01)

Study on circulating tumor DNA and circulating tumor cell detecting minimal residual disease in breast cancer
by: PAN Ruixin, CHEN Xiaosong, SHEN Kunwei
Published: (2022-09-01)

<i>TP53</i>-Mutated Circulating Tumor DNA for Disease Monitoring in Lymphoma Patients after CAR T Cell Therapy
by: Liting Chen, et al.
Published: (2021-05-01)

Individualized Mutation Detection in Circulating Tumor DNA for Monitoring Colorectal Tumor Burden Using a Cancer-Associated Gene Sequencing Panel.
by: Kei A Sato, et al.
Published: (2016-01-01)

Identification and monitoring of mutations in circulating cell-free tumor DNA in hepatocellular carcinoma treated with lenvatinib
by: Yasutoshi Fujii, et al.
Published: (2021-06-01)

Landscape of somatic mutations in different subtypes of advanced breast cancer with circulating tumor DNA analysis
by: Zongbi Yi, et al.
Published: (2017-07-01)

Identifying Circulating Tumor DNA Mutation Profiles in Metastatic Breast Cancer Patients with Multiline Resistance
by: Zhe-Yu Hu, et al.
Published: (2018-06-01)

TNER: a novel background error suppression method for mutation detection in circulating tumor DNA
by: Shibing Deng, et al.
Published: (2018-10-01)

Mutated circulating tumor DNA as a liquid biopsy in lung cancer detection and treatment
by: Martyna Filipska, et al.
Published: (2021-06-01)

Utility of Circulating Tumor DNA for Detection and Monitoring of Endometrial Cancer Recurrence and Progression
by: Esther L. Moss, et al.
Published: (2020-08-01)

Somatic TP53 Mutations Are Detectable in Circulating Tumor DNA from Children with Anaplastic Wilms Tumors
by: Taryn D. Treger, et al.
Published: (2018-12-01)

PIK3CA hotspot mutations in circulating tumor cells and paired circulating tumor DNA in breast cancer: a direct comparison study
by: Eleni Tzanikou, et al.
Published: (2019-12-01)

Applications of Circulating Tumor Cells and Circulating Tumor DNA in Precision Oncology for Breast Cancers
by: Sridevi Addanki, et al.
Published: (2022-07-01)

Role of circulating tumor DNA and circulating tumor cells in breast cancer: History and updates
by: Julien Chedid, et al.
Published: (2022-02-01)

The Use of Circulating Tumor DNA to Monitor and Predict Response to Treatment in Colorectal Cancer
by: Mifanwy Reece, et al.
Published: (2019-11-01)

Patient specific circulating tumor DNA fingerprints to monitor treatment response across multiple tumors
by: Jiaping Li, et al.
Published: (2020-08-01)

Clinical Implications of Monitoring ESR1 Mutations by Circulating Tumor DNA in Estrogen Receptor Positive Metastatic Breast Cancer: A Pilot Study
by: Xuelu Li, et al.
Published: (2020-02-01)

Targeted Next-Generation Sequencing of Circulating Tumor DNA Mutations among Metastatic Breast Cancer Patients
by: Min-Ying Sun, et al.
Published: (2021-06-01)

The diagnostic accuracy of mutations by circulating tumor DNA in breast cancer: an individual patient data meta-analysis
by: Antonio Galvano, et al.
Published: (2022-09-01)

Mutations in circulating tumor DNA detected in the postoperative period predict poor survival in patients with ovarian cancer
by: Angel Chao, et al.
Published: (2023-10-01)

Fragment Enrichment of Circulating Tumor DNA With Low-Frequency Mutations
by: Xiaojun Liu, et al.
Published: (2020-02-01)

Genetic alteration and mutation profiling of circulating cell-free tumor DNA (cfDNA) for diagnosis and targeted therapy of gastrointestinal stromal tumors
by: Weixin Yan, et al.
Published: (2016-07-01)

Circulating tumor DNA in cancer diagnosis, monitoring, and prognosis
by: Sudeepto Saha, et al.
Published: (2022-02-01)

Rapid Multiplex Strip Test for the Detection of Circulating Tumor DNA Mutations for Liquid Biopsy Applications
by: Panagiota M. Kalligosfyri, et al.
Published: (2022-02-01)

Feasibility of Monitoring Response to Metastatic Prostate Cancer Treatment with a Methylation-Based Circulating Tumor DNA Approach
by: Thomas Büttner, et al.
Published: (2024-01-01)

Advances in the Detection Technologies and Clinical Applications of Circulating Tumor DNA in Metastatic Breast Cancer
by: Liao H, et al.
Published: (2020-05-01)

Editorial: Circulating tumor DNA in cancer: a role as a response and monitoring “next-generation” biomarker in cancer therapy
by: Saeid Latifi-Navid, et al.
Published: (2023-06-01)

Circulating Tumor DNA as Biomarkers for Cancer Detection
by: Xiao Han, et al.
Published: (2017-04-01)

Electrochemical Biosensors for Circulating Tumor DNA Detection
by: Ke Wang, et al.
Published: (2022-08-01)

Potential predictive value of circulating tumor DNA (ctDNA) mutations for the efficacy of immune checkpoint inhibitors in advanced triple-negative breast cancer
by: Qiaorui Tan, et al.
Published: (2023-03-01)

Monitoring treatment efficacy and resistance in breast cancer patients via circulating tumor DNA genomic profiling
by: Zhanhong Chen, et al.
Published: (2020-02-01)

Current Status of Circulating Tumor Cells, Circulating Tumor DNA, and Exosomes in Breast Cancer Liquid Biopsies
by: Marta Tellez-Gabriel, et al.
Published: (2020-12-01)

Blood-based biomarkers in breast cancer: From proteins to circulating tumor cells to circulating tumor DNA
by: Michael J Duffy, et al.
Published: (2018-05-01)

Preoperative detection of KRAS mutated circulating tumor DNA is an independent risk factor for recurrence in colorectal cancer
by: Yuki Nakamura, et al.
Published: (2021-01-01)

Diagnostic accuracy of droplet digital PCR for detection of EGFR T790M mutation in circulating tumor DNA
by: Zhang R, et al.
Published: (2018-05-01)

The Mutational Landscape of Pancreatic and Liver Cancers, as Represented by Circulating Tumor DNA
by: Alistair Rice, et al.
Published: (2019-09-01)

Concordance between the tumor mutational status and circulating tumor DNA in patients with colorectal cancer
by: E. M. Polyanskaya, et al.
Published: (2022-04-01)

Circulating Tumor DNA Detection in the Management of Anti-EGFR Therapy for Advanced Colorectal Cancer
by: Franciele H. Knebel, et al.
Published: (2019-03-01)

Personalized monitoring of circulating tumor DNA with a specific signature of trackable mutations after chimeric antigen receptor T-cell therapy in follicular lymphoma patients
by: Ana Jiménez-Ubieto, et al.
Published: (2023-06-01)